Icon applies data insights to trial monitoring; Quanterix adds biomarker detection tool;

> CRO Icon has adopted a data-driven system to guide central and on-site trial monitoring. Release

> Quanterix has introduced a tool for detecting biomarkers at low concentrations. Piece

> A computer analysis of tumor samples suggests previous research may have overestimated the role of viruses in cancer. Research

> Litera has acquired clinical trial portal AxxiTRIALS. News

> Hamner Institutes has teamed up with Certara to improve modeling of drug-induced liver injury. Item

> Cresset is to add lead optimization capabilities to its drug discovery software platforms. Article

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.